Correlation Between 89bio and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both 89bio and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Pliant Therapeutics, you can compare the effects of market volatilities on 89bio and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Pliant Therapeutics.
Diversification Opportunities for 89bio and Pliant Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 89bio and Pliant is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of 89bio i.e., 89bio and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between 89bio and Pliant Therapeutics
Given the investment horizon of 90 days 89bio Inc is expected to generate 1.22 times more return on investment than Pliant Therapeutics. However, 89bio is 1.22 times more volatile than Pliant Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 878.00 in 89bio Inc on November 2, 2024 and sell it today you would earn a total of 86.00 from holding 89bio Inc or generate 9.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
89bio Inc vs. Pliant Therapeutics
Performance |
| Timeline |
| 89bio Inc |
| Pliant Therapeutics |
89bio and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 89bio and Pliant Therapeutics
The main advantage of trading using opposite 89bio and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| 89bio vs. Madrigal Pharmaceuticals | 89bio vs. Pliant Therapeutics | 89bio vs. Arcellx | 89bio vs. Stoke Therapeutics |
| Pliant Therapeutics vs. Surrozen | Pliant Therapeutics vs. Armata Pharmaceuticals | Pliant Therapeutics vs. Pasithea Therapeutics Corp | Pliant Therapeutics vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |